Hypomethylating therapy and autoimmunity in MDS: an enigmatic relationship.

MLA

Kotsianidis, Ioannis, et al. “Hypomethylating Therapy and Autoimmunity in MDS: An Enigmatic Relationship.” Leukemia Research, vol. 36, no. 4, Apr. 2012, pp. e90–92. EBSCOhost, https://doi.org/10.1016/j.leukres.2011.12.013.

APA

Kotsianidis, I., Spanoudakis, E., Nakou, E., Miltiades, P., Margaritis, D., Tsatalas, C., Tzouvelekis, A., & Oikonomou, A. (2012). Hypomethylating therapy and autoimmunity in MDS: an enigmatic relationship. Leukemia Research, 36(4), e90–e92. https://doi.org/10.1016/j.leukres.2011.12.013

Chicago

Kotsianidis, Ioannis, Emmanouil Spanoudakis, Evangelia Nakou, Paraskevi Miltiades, Dimitrios Margaritis, Costas Tsatalas, Argyrios Tzouvelekis, and Anastasia Oikonomou. 2012. “Hypomethylating Therapy and Autoimmunity in MDS: An Enigmatic Relationship.” Leukemia Research 36 (4): e90–92. doi:10.1016/j.leukres.2011.12.013.